Cystic fibrosis transmembrane conductance regulator (ABCC7) structure

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 2, 2013, Pages

  Hunt, John F ^a   Wang, Chi ^a   Ford, Robert C ^b  

^a Howard Hughes Medical Institute   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CARRIER PROTEIN; CFTR PROTEIN, HUMAN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; NUBP1 PROTEIN, HUMAN;

CHEMISTRY; CRYSTALLIZATION; GENETICS; HUMAN; MUTATION; PROTEIN FOLDING; REVIEW;

ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; CRYSTALLIZATION; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GTP-BINDING PROTEINS; HUMANS; MEMBRANE PROTEINS; MUTATION; PROTEIN FOLDING;

MLCS; MLOWN;

EID: 84874710058     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a009514     Document Type: Article

References (150)

1. Aleksandrov A.A., Aleksandrov L, Riordan JR. 2002a. Nucleoside triphosphate pentose ring impact on CFTR gating and hydrolysis. FEBS Lett 518: 183-188.
2. Aleksandrov L., Aleksandrov AA, Chang XB, Riordan JR. 2002b. The first nucleotide binding domain of cystic fibrosis transmembrane conductance regulator is a site of stable nucleotide interaction, whereas the second is a site of rapid turnover. J Biol Chem 277: 15419-15425.
3. Aleksandrov A.A., Aleksandrov LA, Riordan JR. 2007. CFTR (ABCC7) is a hydrolyzable-ligand-gated channel. Pflugers Arch 453: 693-702.
4. 2+dependent ATP occlusion at the first nucleotide-binding domain (NBD1) of CFTR does not require the second (NBD2). Biochem J 416: 129-136.
5. Aleksandrov A.A., Cui L, Riordan JR. 2009. Relationship between nucleotide binding and ion channel gating in cystic fibrosis transmembrane conductance regulator. J Physiol 587: 2875-2886.
6. Aleksandrov A.A., Kota P, Aleksandrov LA, He L, Jensen T, Cui L., Gentzsch M, Dokholyan NV, Riordan JR. 2010. Regulatory insertion removal restores maturation, stability and function of dF508 CFTR. J Mol Biol 401: 194-210.
7. Aleksandrov A.A., Kota P, Cui L, Jensen T, Alekseev AE, Reyes S., He L, Gentzsch M, Aleksandrov LA, Dokholyan NV, et al. 2012. Allosteric modulation balances thermodynamic stability and restores function of dF508 CFTR. J Mol Biol 419: 41-60.
8. Alexander C., Ivetac A, Liu X, Norimatsu Y, Serrano JR, Landstrom A., Sansom M, Dawson DC. 2009. Cystic fibrosis transmembrane conductance regulator: Using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore. Biochemistry 48: 10078-10088.
9. Aller S.G., Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell P.M., Trinh YT, Zhang Q, Urbatsch IL, et al. 2009. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323: 1718-1722.
10. Anderson M.P., Berger HA, Rich DP, Gregory RJ, Smith AE, Welsh MJ. 1991a. Nucleoside triphosphates are required to open the CFTR chloride channel. Cell 67: 775-784.
11. Anderson M.P., Gregory RJ, Thompson S, Souza DW, Paul S, Mulligan R.C., Smith AE, Welsh MJ. 1991b. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253: 202-205.
12. Arai M., Kuwajima K. 2000. Role of the molten globule state in protein folding. Adv Protein Chem 53: 209-282.
13. Atwell S., Brouillette CG, Conners K, Emtage S, Gheyi T, Guggino W.B., Hendle J, Hunt JF, Lewis HA, Lu F, et al. 2010. Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant. Protein Eng Des Sel 23: 375-384.
14. +-ATPase in the open conformation. Nature 392: 840-843.
15. +-ATPase on a carbon support film for electron crystallography. J Mol Biol 287: 961-968.
16. Awayn NH. 2008. Structural analyses of the human cystic fibrosis transmembrane conductance regulator (CFTR) protein using electron microscopy, PhD thesis, University of Manchester, Manchester, UK.
17. Awayn N.H., Rosenberg MF, Kamis AB, Aleksandrov LA, Riordan J.R., Ford RC. 2005. Crystallographic and single-particle analyses of native-and nucleotide-bound forms of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Biochem Soc Trans 33: 996-999.
18. Baker J.M., Hudson RP, Kanelis V, Choy WY, Thibodeau PH, Thomas P.J., Forman-Kay JD. 2007. CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat Struct Mol Biol 14: 738-745.
19. Barthelme D., Dinkelaker S, Albers SV, Londei P, Ermler U, Tampé R. 2011. Ribosome recycling depends on a mechanistic link between the FeS cluster domain and a conformational switch of the twin-ATPase ABCE1. Proc Natl Acad Sci 108: 3228-3233.
20. Cai Z., Scott-Ward TS, Sheppard DN. 2003. Voltage-dependent gating of the cystic fibrosis transmembrane conductance regulator Cl-channel. J Gen Physiol 122: 605-620.
21. Callebaut I., Eudes R, Mornon JP, Lehn P. 2004. Nucleotidebinding domains of human cystic fibrosis transmembrane conductance regulator: Detailed sequence analysis and three-dimensional modeling of the heterodimer. Cell Molec Life Sci 61: 230-242.
22. Chappe V., Hinkson DA, Howell LD, Evagelidis A, Liao J, Chang X.B., Riordan JR, Hanrahan JW. 2004. Stimulatory and inhibitory protein kinase C consensus sequences regulate the cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci 101: 390-395.
23. Chappe V., Irvine T, Liao J, Evagelidis A, Hanrahan JW. 2005. Phosphorylation of CFTR by PKA promotes binding of the regulatory domain. EMBO J 24: 2730-2740.
24. Chen C.J., Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB. 1986. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381-389.
25. Chen J., Lu G, Lin J, Davidson AL, Quiocho FA. 2003. A tweezers-like motion of the ATP-binding cassette dimer in an ABC transport cycle. Mol Cell 12: 651-661.
26. Csanády L, ChanKW, Seto-YoungD, Kopsco DC, Nairn AC, Gadsby DC. 2000. Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains. J Gen Physiol 116: 477-500.
27. Csanády L, Seto-Young D, Chan KW, Cenciarelli C, Angel B.B., Qin J, McLachlin DT, Krutchinsky AN, Chait B.T., Nairn AC, et al. 2005. Preferential phosphorylation of R-domain Serine 768 dampens activation of CFTR channels by PKA. J Gen Physiol 125: 171-186.
28. Csanády L, Nairn AC, Gadsby DC. 2006. Thermodynamics of CFTR channel gating: A spreading conformational change initiates an irreversible gating cycle. J Gen Physiol 128: 523-533.
29. Cui J., Davidson AL. 2011. ABC solute importers in bacteria. Essays Biochem 50: 85-99.
30. Cutting GR. 1993. Spectrum of mutations in cystic fibrosis. J Bioenerg Biomembr 25: 7-10.
31. Cutting GR. 2005. Modifier genetics: Cystic fibrosis. Annu Rev Genomics Hum Genet 6: 237-260.
32. Dalton J., Kalid O, Schushan M, Ben-Tal N, Villa-Freixa J. 2012. New model of CFTR proposes active channel-like conformation. J Chem Inf Model doi: 10.1021/ci2005884.
33. Da Paula AC, Sousa M, Xu Z, Dawson ES, Boyd AC, Sheppard D.N., Amaral MD. 2010. Folding and rescue of a cystic fibrosis transmembrane conductance regulator trafficking mutant identified using human-murine chimeric proteins. J Biol Chem 285: 27033-27044.
34. Dassa E., Bouige P. 2001. The ABC of ABCS: A phylogenetic and functional classification of ABC systems in living organisms. Res Microbiol 152: 211-229.
35. Davidson A.L., Chen J. 2004. ATP-binding cassette transporters in bacteria. Annu Rev Biochem 73: 241-268.
36. Davidson A.L., Maloney PC. 2007. ABC transporters: How small machines do a big job. Trends Microbiol 15: 448-455.
37. Davidson A.L., Sharma S. 1997. Mutation of a single MalK subunit severely impairs maltose transport activity in Escherichia coli. J Bacteriol 179: 5458-5464.
38. Davidson A.L., Laghaeian SS, Mannering DE. 1996. The maltose transport system of Escherichia coli displays positive cooperativity in ATP hydrolysis. J Biol Chem 271: 4858-4863.
39. Dawson R.J., Locher KP. 2006. Structure of a bacterial multidrug ABC transporter. Nature 443: 180-185.
40. Dawson R.J., Locher KP. 2007. Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP. FEBS Lett 581: 935-938.
41. Dawson R.J., Hollenstein K, Locher KP. 2007. Uptake or extrusion: Crystal structures of full ABC transporters suggest a common mechanism. Mol Microbiol 65: 250-257.
42. Dean M. 2005. The genetics of ATP-binding cassette transporters. Methods Enzymol 400: 409-429.
43. Dean M., Annilo T. 2005. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet 6: 123-142.
44. Dean M., Rzhetsky A, Allikmets R. 2001. The human ATPbinding cassette (ABC) transporter superfamily. Genome Res 11: 1156-1166.
45. DeCarvalho AC, Gansheroff LJ, Teem JL. 2002. Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator δ f508. J Biol Chem 277: 35896-35905.
46. Diederichs K., Diez J, Greller G, Müller C, Breed J, Schnell C, Vonrhein C., Boos W, Welte W. 2000. Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis. EMBO J 19: 5951-5961.
47. Drumm M.L., Wilkinson DJ, Smit LS, Worrell RT, Strong TV, Frizzell R.A., Dawson DC, Collins FS. 1991. Chloride conductance expressed by δ F508 and other mutant CFTRs in Xenopus oocytes. Science 254: 1797-1799.
48. Englander SW. 2000. Protein folding intermediates and pathways studied by hydrogen exchange. Annu Rev Biophys Biomol Struct 29: 213-238.
49. Fojo A.T., Whang-Peng J, Gottesman MM, Pastan I. 1985. Amplification of DNA sequences in human multidrugresistant KB carcinoma cells. Proc Natl Acad Sci 82: 7661-7665.
50. Ford R.C., Holzenburg A. 2008. Electron crystallography of biomolecules: Mysterious membranes and missing cones. Trends Biochem Sci 33: 38-43.
51. Ford R.C., Birtley J, Rosenberg MF, Zhang L. 2011. CFTR three-dimensional structure. Methods Mol Biol 741: 329-346.
52. Gadsby DC. 2004. Ion transport: Spot the difference. Nature 427: 795-797.
53. Gadsby D.C., Vergani P, Csanady L. 2006. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440: 477-483.
54. George A.M., Jones PM. 2012. Perspectives on the structurefunction of ABC transporters: The switch and constant contact models. Prog Biophys Mol Biol 109: 95-107.
55. Gerlach J.H., Endicott JA, Juranka PF, Henderson G, Sarangi F., Deuchars KL, Ling V. 1986. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324: 485-489.
56. Gregory R.J., Cheng SH, Rich DP, Marshall J, Paul S, Hehir K, Ostedgaard L., Klinger KW, Welsh MJ, Smith AE. 1990. Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 347: 382-386.
57. Griko Y.V., Privalov PL. 1994. Thermodynamic puzzle of apomyoglobin unfolding. J Mol Biol 235: 1318-1325.
58. Griko Y.V., Gittis A, Lattman EE, Privalov PL. 1994. Residual structure in a staphylococcal nuclease fragment. Is it a molten globule and is its unfolding a first-order phase transition? J Mol Biol 243: 93-99.
59. Haggie P.M., Kim JK, Lukacs GL, Verkman AS. 2006. Tracking of quantum dot-labeled CFTR shows near immobilization by C-terminal PDZ interactions. Mol Biol Cell 17: 4937-4945.
60. Harris JR. 1999. Negative staining of thinly spread biological particulates. Methods Mol Biol 117: 13-30.
61. He L., Aleksandrov LA, Cui L, Jensen TJ, Nesbitt KL, Riordan JR. 2010. Restoration of domain folding and interdomain assembly by second-site suppressors of the dF508 mutation in CFTR. FASEB J 24: 3103-3112.
62. Higgins CF. 1992. ABC transporters: From microorganisms to man. Annu Rev Cell Bio 8: 67-113.
63. Hobson A.C., Weatherwax R, Ames GF. 1984. ATP-binding sites in the membrane components of histidine permease, a periplasmic transport system. ProcNatl Acad Sci 81: 7333-7337.
64. Hollenstein K., Dawson RJ, Locher KP. 2007a. Structure and mechanism of ABC transporter proteins. Curr Opin Struct Biol 17: 412-418.
65. Hollenstein K., Frei DC, Locher KP. 2007b. Structure of an ABC transporter in complex with its binding protein. Nature 446: 213-216.
66. Hopfner K.P., Karcher A, Shin DS, Craig L, Arthur LM, Carney J.P., Tainer JA. 2000. Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily. Cell 101: 789-800.
67. Horn C., Bremer E, Schmitt L. 2003. Nucleotide dependent monomer/dimer equilibrium of OpuAA, the nucleotide-binding protein of the osmotically regulated ABC transporter OpuA from Bacillus subtilis. J Mol Biol 334: 403-419.
68. Hung L.W., Wang IX, Nikaido K, Liu PQ, Ames GF, Kim SH. 1998. Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 396: 703-707.
69. Hunt J.F., Weinkauf S, Henry L, Fak JJ, McNicholas P, Oliver D.B., Deisenhofer J. 2002. Nucleotide control of interdomain interactions in the conformational reaction cycle of SecA. Science 297: 2018-2026.
70. Hwang T.C., Sheppard DN. 2009. Gating of the CFTR Clchannel by ATP-driven nucleotide-binding domain dimerisation. J Physiol 587: 2151-2161.
71. Janas E., Hofacker M, Chen M, Gompf S, van der Does C, Tampé R. 2003. The ATP hydrolysis cycle of the nucleotide-binding domain of the mitochondrial atp-binding cassette transporter Mdl1p. J Biol Chem 278: 26862-26869.
72. Jones P.M., George AM. 1999. Subunit interactions in ABC transporters: Towards a functional architecture. FEMS Microbiol Lett 179: 187-202.
73. Jones P.M., George AM. 2004. The ABC transporter structure and mechanism: Perspectives on recent research. CellMol Life Sci 61: 682-699.
74. Jordan I.K., Kota KC, Cui G, Thompson CH, McCarty NA. 2008. Evolutionary and functional divergence between the cystic fibrosis transmembrane conductance regulator and related ATP-binding cassette transporters. Proc Natl Acad Sci 105: 18865-18870.
75. Kadaba N.S., Kaiser JT, Johnson E, Lee A, Rees DC. 2008. The high-affinity E. coli methionine ABC transporter: Structure and allosteric regulation. Science 321: 250-253.
76. Kanelis V., Hudson RP, Thibodeau PH, Thomas PJ, Forman-Kay JD. 2010. NMR evidence for differential phosphorylation-dependent interactions in WTand dF508 CFTR. EMBO J 29: 263-277.
77. Karpowich N., Martsinkevich O, Millen L, Yuan YR, Dai PL, MacVey K, Thomas PJ, Hunt JF. 2001. Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. Structure 9: 571-586.
78. Kerr ID. 2002. Structure and association of ATP-binding cassette transporter nucleotide-binding domains. Biochim Biophys Acta 1561: 47-64.
79. Kerr ID. 2004. Sequence analysis of twin ATP binding cassette proteins involved in translational control, antibiotic resistance, and ribonuclease L inhibition. Biochem Biophys Res Commun 315: 166-173.
80. Khare D., Oldham ML, Orelle C, Davidson AL, Chen J. 2009. Alternating access in maltose transporter mediated by rigid-body rotations. Mol Cell 33: 528-536.
81. Kim Chiaw P, Eckford PD, Bear CE. 2011. Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy. Essays Biochem 50: 233-248.
82. Kloch M., Milewski M, Nurowska E, Dworakowska B, Cutting GR, Dolowy K. 2010. The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing. Cell Physiol Biochem 25: 169-180.
83. Kos V., Ford RC. 2009. The ATP-binding cassette family: A structural perspective. Cell Mol Life Sci 66: 3111-3126.
84. Lewis H.A., Buchanan SG, Burley SK, Conners K, Dickey M, Dorwart M, Fowler R, Gao X, Guggino WB, HendricksonWA, et al. 2004. Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J 23: 282-293.
85. Lewis H.A., Zhao X, Wang C, Sauder JM, Rooney I, Noland BW, Lorimer D, Kearins MC, Conners K, Condon B, et al. 2005. Impact of the dF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem 280: 1346-1353.
86. Lewis H.A., Wang C, Zhao X, Hamuro Y, Conners K, Kearins M.C., Lu F, Sauder JM, Molnar KS, Coales SJ, et al. 2010. Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry. J Mol Biol 396: 406-430.
87. Linsdell P. 2006. Mechanism of chloride permeation in the cystic fibrosis transmembrane conductance regulator chloride channel. Exp Physiol 91: 123-129.
88. Linsdell P., Evagelidis A, Hanrahan JW. 2000. Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore. Biophys J 78: 2973-2982.
89. Linton K.J., Higgins CF. 1998. The Escherichia coli ATP-binding cassette (ABC) proteins. Mol Microbiol 28: 5-13.
90. Liu X., Dawson DC. 2011. Cystic fibrosis transmembrane conductance regulator: Temperature-dependent cysteine reactivity suggests different stable conformers of the conduction pathway. Biochemistry 50: 10311-10317.
91. Liu X., Smith SS, Dawson DC. 2003. CFTR: What's it like inside the pore? J Exp Zoolog AComp Exp Biol 300: 69-75.
92. Liu X., Zhang ZR, Fuller MD, Billingsley J, McCarty NA, Dawson DC. 2004. CFTR: A cysteine at position 338 in TM6 senses a positive electrostatic potential in the pore. Biophys J 87: 3826-3841.
93. Locher K.P., Lee AT, Rees DC. 2002. The E. coli BtuCD structure: A framework for ABC transporter architecture and mechanism. Science 296: 1091-1098.
94. Loo T.W., Bartlett MC, Clarke DM. 2010. The V510D suppressor mutation stabilizes dF508-CFTR at the cell surface. Biochemistry doi: 10.1021/bi100807h.
95. Mansoura M.K., Smith SS, Choi AD, Richards NW, Strong TV, Drumm ML, Collins FS, Dawson DC. 1998. Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys J 74: 1320-1332.
96. McDevitt CA, Shintre CA, Grossmann JG, Pollock NL, Prince S.M., Callaghan R, Ford RC. 2008. Structural insights into P-glycoprotein (ABCB1) by small angle X-ray scattering and electron crystallography. FEBS Lett 582: 2950-2956.
97. Mendoza J.L., Schmidt A, Li Q, Nuvaga E, Barrett T, Bridges R.J., Feranchak AP, Brautigam CA, Thomas PJ. 2012. Requirements for efficient correction of dF508 CFTR revealed by analyses of evolved sequences. Cell 148: 164-174.
98. Mense M., Vergani P, White DM, Altberg G, Nairn AC, Gadsby DC. 2006. In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. EMBO J 25: 4728-4739.
99. Mio K., Ogura T, Mio M, Shimizu H, Hwang TC, Sato C, Sohma Y. 2008. Three-dimensional reconstruction of human cystic fibrosis transmembrane conductance regulator chloride channel revealed an ellipsoidal structure with orifices beneath the putative transmembrane domain. J Biol Chem 283: 30300-30310.
100. Moody J.E., Millen L, Binns D, Hunt JF, Thomas PJ. 2002. Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATPbinding cassette transporters. J Biol Chem 277: 21111-21114.
101. Mornon J.P., Lehn P, Callebaut I. 2008. Atomic model of human cystic fibrosis transmembrane conductance regulator: Membrane-spanning domains and coupling interfaces. Cell Mol Life Sci 65: 2594-2612.
102. Mornon J.P., Lehn P, Callebaut I. 2009. Molecular models of the open and closed states of the whole human CFTR protein. Cell Mol Life Sci 66: 3469-3486.
103. Mourez M., Hofnung M, Dassa E. 1997. Subunit interactions in ABC transporters: A conserved sequence in hydrophobic membrane proteins of periplasmic permeases defines an important site of interaction with the ATPase subunits. EMBO J 16: 3066-3077.
104. Oldham M.L., Chen J. 2011. Crystal structure of the maltose transporter in a pretranslocation intermediate state. Science 332: 1202-1205.
105. Oldham M.L., Khare D, Quiocho FA, Davidson AL, Chen J. 2007. Crystal structure of a catalytic intermediate of the maltose transporter. Nature 450: 515-521.
106. Ostedgaard L.S., Rich DP, DeBerg LG, Welsh MJ. 1997. Association of domains within the cystic fibrosis transmembrane conductance regulator. Biochemistry 36: 1287-1294.
107. Pettersen E.F., Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
108. Pinkett H.W., Lee AT, Lum P, Locher KP, Rees DC. 2007. An inward-facing conformation of a putative metal-chelatetype ABC transporter. Science 315: 373-377.
109. Pissarra L.S., Farinha CM, Xu Z, Schmidt A, Thibodeau PH, Cai Z., Thomas PJ, Sheppard DN, Amaral MD. 2008. Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. Chem Biol 15: 62-69.
110. Protasevich I., Yang Z, Wang C, Atwell S, Zhao X, Emtage S, Wetmore D., Hunt JF, Brouillette CG. 2010. Thermal unfolding studies show the disease causing F508 deletion mutation in cystic fibrosis transmembrane conductance regulator (CFTR) thermodynamically destabilizes nucleotide-binding domain 1. Protein Sci 19: 1917-1931.
111. Qu B.H., Strickland EH, Thomas PJ. 1997. Localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. J Biol Chem 272: 15739-15744.
112. Rabeh W.M., Bossard F, Xu H, Okiyoneda T, Bagdany M, Mulvihill C.M., Du K, di Bernardo S, Liu Y, Konermann L, et al. 2012. Correction of both NBD1 energetics and domain interface is required to restore dF508 CFTR folding and function. Cell 148: 150-163.
113. Redfield C. 2004. Using nuclear magnetic resonance spectroscopy to study molten globule states of proteins. Methods 34: 121-132.
114. Rich D.P., Anderson MP, Gregory RJ, Cheng SH, Paul S, Jefferson D.M., McCann JD, Klinger KW, Smith AE, Welsh MJ. 1990. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347: 358-363.
115. Riordan JR. 2008. CFTR function and prospects for therapy. Annu Rev Biochem 77: 701-726.
116. Riordan J.R., Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z., Zielenski J, Lok S, Plavsic N, Chou JL. 1989. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245: 1066-1073.
117. Roninson I.B., Chin JE, Choi KG, Gros P, Housman DE, Fojo A., Shen DW, Gottesman MM, Pastan I. 1986. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci 83: 4538-4542.
118. Rosenberg M.F., Velarde G, Ford RC, Martin C, Berridge G, Kerr I.D., Callaghan R, Schmidlin A, Wooding C, Linton KJ, et al. 2001. Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle. EMBO J 20: 5615-5625.
119. Rosenberg M.F., Kamis AB, Callaghan R, Higgins CF, Ford RC. 2003. Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding. J Biol Chem 278: 8294-8299.
120. Rosenberg M.F., Kamis AB, Aleksandrov LA, Ford RC, Riordan JR. 2004. Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem 279: 39051-39057.
121. Rosenberg M.F., O'Ryan LP, Hughes G, Zhao Z, Aleksandrov LA, Riordan JR, Ford RC. 2011. The cystic fibrosis transmembrane conductance regulator (CFTR): 3D structure and localisation of a channel gate. J Biol Chem 286: 42647-42654.
122. Sampson H.M., Robert R, Liao J, Matthes E, Carlile GW, Hanrahan J.W., Thomas DY. 2011. Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR. Chem Biol 18: 231-242.
123. Saurin W., Hofnung M, Dassa E. 1999. Getting in or out: Early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters. J Mol Evol 48: 22-41.
124. +-Atpase: An approach to the crystallization of integral membrane-proteins. Acta Crystallogr D Biol Crystallogr 50: 643-649.
125. Schillers H. 2008. Imaging CFTR in its native environment. Pflugers Arch 456: 163-177.
126. Schillers H., Shahin V, Albermann L, Schafer C, Oberleithner H. 2004. Imaging CFTR: A tail to tail dimer with a central pore. Cell Physiol Biochem 14: 1-10.
127. Serohijos A.W., Hegedus T, Aleksandrov AA, He L, Cui L, Dokholyan N.V., Riordan JR. 2008. Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci 105: 3256-3261.
128. Sheppard DN. 2004. CFTR channel pharmacology: Novel pore blockers identified by high-throughput screening. J Gen Physiol 124: 109-113.
129. Sheppard D.N., Welsh MJ. 1999. Structure and function of the CFTR chloride channel. Physiol Rev 79: S23-S45.
130. Sheppard D.N., Rich DP, Ostedgaard LS, Gregory RJ, Smith AE, Welsh MJ. 1993. Mutations in CFTR associated with mild-disease-form Cl-channels with altered pore properties. Nature 362: 160-164.
131. Smith P.C., Karpowich N, Millen L, Moody JE, Rosen J, Thomas P.J., Hunt JF. 2002. ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell 10: 139-149.
132. + proteins: Diversity in function, similarity in structure. Biochem Soc Trans 36: 72-77.
133. Stenham D.R., Campbell JD, Sansom MS, Higgins CF, Kerr ID, Linton KJ. 2003. An atomic detail model for the human ATP binding cassette transporter P-glycoprotein derived from disulfide cross-linking and homology modeling. FASEB J 17: 2287-2289.
134. Teem J.L., Berger HA, Ostedgaard LS, Rich DP, Tsui LC, Welsh MJ. 1993. Identification of revertants for the cystic fibrosis δ F508 mutation using STE6-CFTR chimeras in yeast. Cell 73: 335-346.
135. Thibodeau P.H., Brautigam CA, Machius M, Thomas PJ. 2005. Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol 12: 10-16.
136. Thibodeau P.H., Richardson JM, Wang W, Millen L, Watson J, Mendoza JL, Du K, Fischman S, Senderowitz H, Lukacs G.L., et al. 2010. The cystic fibrosis-causing mutation dF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J Biol Chem 285: 35825-35835.
137. Thomas P.J., Shenbagamurthi P, Ysern X, Pedersen PL. 1991. Cystic fibrosis transmembrane conductance regulator: Nucleotide binding to a synthetic peptide. Science 251: 555-557.
138. Vergani P., Nairn AC, Gadsby DC. 2003. On the mechanism of MgATP-dependent gating of CFTR Cl-channels. J Gen Physiol 121: 17-36.
139. Vergani P., Lockless SW, Nairn AC, Gadsby DC. 2005. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433: 876-880.
140. Walker J.E., Saraste M, Runswick MJ, Gay NJ. 1982. Distantly related sequences in the α-and β-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1: 945-951.
141. Wang C., Protasevich I, Yang Z, Seehausen D, Skalak T, Zhao X., Atwell S, Spencer Emtage J, Wetmore DR, Brouillette C.G., et al. 2010. Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis. Protein Sci 19: 1932-1947.
142. Ward A., Reyes CL, Yu J, Roth CB, Chang G. 2007. Flexibility in the ABC transporter MsbA: Alternating access with a twist. Proc Natl Acad Sci 104: 19005-19010.
143. Yuan Y.R., Blecker S, Martsinkevich O, Millen L, Thomas PJ, Hunt JF. 2001. The crystal structure of the MJ0796 ATP-binding cassette. Implications for the structural consequences of ATP hydrolysis in the active site of an ABC transporter. J Biol Chem 276: 32313-32321.
144. Zaitseva J., Jenewein S, Jumpertz T, Holland IB, Schmitt L. 2005. H662 is the linchpin of ATP hydrolysis in the nucleotide-binding domain of the ABC transporter HlyB. EMBO J 24: 1901-1910.
145. Zhang L., Aleksandrov LA, Zhao Z, Birtley JR, Riordan JR, Ford RC. 2009. Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding. J Struct Biol 167: 242-251.
146. Zhang L., Aleksandrov LA, Riordan JR, Ford RC. 2010. Domain location within the cystic fibrosis transmembrane conductance regulator protein investigated by electron microscopy and gold labelling. Biochim Biophys Acta 1808: 399-404.
147. Zhu T., Hinkson DA, Dahan D, Evagelidis A, Hanrahan JW. 2002. CFTR regulation by phosphorylation. Methods Mol Med 70: 99-109.
148. Zolnerciks J.K., Wooding C, Linton KJ. 2007. Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein. FASEB J 21: 3937-3948.
149. Zolnerciks J.K., Andress EJ, Nicolaou M, Linton KJ. 2011. Structure of ABC transporters. Essays Biochem 50: 43-61.
150. Zutz A., Hoffmann J, Hellmich UA, Glaubitz C, Ludwig B, Brutschy B., Tampé R. 2010. Asymmetric ATP hydrolysis cycle of the heterodimeric multidrug ABC transport complex TmrAB from Thermus thermophilus. J Biol Chem 286: 7104-7115.